These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8590859)

  • 1. The physiologic role and therapeutic potential of the Mpl-ligand in thrombopoiesis.
    Hunt P
    Stem Cells; 1995 Nov; 13(6):579-87. PubMed ID: 8590859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biology of thrombopoietin and its receptors].
    Robak T
    Postepy Hig Med Dosw; 1996; 50(6):649-63. PubMed ID: 9064684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin: biology and clinical potentials.
    Miyazaki H; Kato T
    Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure, biology and potential therapeutic applications of recombinant thrombopoietin.
    Lok S; Foster DC
    Stem Cells; 1994 Nov; 12(6):586-98. PubMed ID: 7881359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megakaryocyte development and platelet production.
    Deutsch VR; Tomer A
    Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of megakaryopoiesis and thrombopoiesis by thrombopoietin].
    Oda A; Ikeda Y
    Rinsho Byori; 1998 May; 46(5):430-4. PubMed ID: 9627493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin: the primary regulator of megakaryocyte and platelet production.
    Kaushansky K
    Thromb Haemost; 1995 Jul; 74(1):521-5. PubMed ID: 8578518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombopoietic growth factor--thrombopoietin. Molecular and biological properties].
    Skotnicki AB; Jabłoński MJ
    Przegl Lek; 1996; 53(11):826-9. PubMed ID: 9173448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of thrombopoietin (c-Mpl Ligand)].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1998; 51(11-12):501-8. PubMed ID: 10081270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombopoietin and megakaryocyte differentiation].
    Vainchenker W; Debili N; Norol F; Wendling F
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1575-81. PubMed ID: 9824885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Mpl ligands on platelet production and function in nonhuman primates.
    Harker LA; Marzec UM; Kelly AB
    Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin (Mpl ligand) and the regulation of platelet production.
    Cohen-Solal K; Debili N; Vainchenker W; Wendling F
    Eur Cytokine Netw; 1997 Sep; 8(3):311-4. PubMed ID: 9346371
    [No Abstract]   [Full Text] [Related]  

  • 13. Megakaryocyte growth and development factor (MGDF): an Mpl ligand and cytokine that regulates thrombopoiesis.
    Neumann TA; Foote M
    Cytokines Cell Mol Ther; 2000 Mar; 6(1):47-56. PubMed ID: 10976539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
    Murone M; Carpenter DA; de Sauvage FJ
    Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of platelet growth factors in cancer therapy.
    Clarke K; Basser RL
    Stem Cells; 1996; 14 Suppl 1():274-80. PubMed ID: 11012231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
    Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
    Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin: its role from early hematopoiesis to platelet production.
    Wendling F
    Haematologica; 1999 Feb; 84(2):158-66. PubMed ID: 10091415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production.
    Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS
    Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness.
    Mintern J; Williams N; Jackson H
    Exp Hematol; 1997 Nov; 25(12):1233-9. PubMed ID: 9357966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.